Pediatric Ophthalmology/Strabismus Panel - 2022 Financial Disclosures
David K. Wallace, MD, MPH, Chair
National Eye Institute - S
Oscar A. Cruz, MD
No financial relationships to disclose
Amy Hutchinson, MD
No financial relationships to disclose
Scott R. Lambert, MD
EyePoint Pharmaceuticals - S
Christie L. Morse, MD
OMIC, Sydnexis - C
AAPOS - S
Sydnexis - PS
Sydnexis - SO
Michael X. Repka, MD, MBA, Consultant
Abbvie, Alcon Laboratories, Inc., Luminopia - C
American Academy of Ophthalmology, National Eye Institute - S
Derek T. Sprunger, MD
No financial relationships to disclose
Amra Hercinovic, MPH, Methodologist
No financial relationships to disclose
KEY:
C = Consultant/Advisor (consultant fee, paid advisory boards or fees for attending a meeting [for the past 1 year])
E = Employee (employed by a commercial entity)
L = Lecture Fees (lecture fees [honoraria], travel fees or reimbursement when speaking at the invitation of a commercial entity
S = Grant Support (grant support for the past 1 year [all sources] and all sources used for this project if this form is an update for a specific talk or manuscript with no time limitation)